The global syphilis testing market size reached US$ 1.2 Billion in 2023. Looking forward, the market is projected to reach US$ 1.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.24% during 2023-2032. The growing prevalence of sexually transmitted diseases (STDs), the increasing incidences of miscarriages, and the rising need for effective disease diagnosing and testing solutions in the healthcare sector represent some of the key factors driving the market.
Syphilis refers to a sexually transmitted infection (STI) that is usually caused by sexual contact and is spread amongst individuals through the skin or mucous membrane contact. It starts as a painless sore on the genitals and rectum of the mouth. If left untreated, it might trigger complications of tertiary syphilis, wherein the disease may damage the brain, nerves, blood vessels, and joints.
At present, rapid plasma reagin (RPR) and venereal diseases research laboratory (VDRL) are standard testing practices that are being used by practitioners. These approaches provide early detection for better treatment and mitigate the spread and development of sexually transmitted diseases (STDs). As a result, syphilis testing is frequently used in laboratories and point-of-care (PoC) centers to diagnose the syphilis type and identify its proper treatment.
Additionally, the convenience of usage and the easy availability of these test kits at online retail stores and in-store pharmacies at affordable price points are contributing to the market growth. Apart from this, the considerable improvements in the healthcare sector and the recent research and development (R&D) activities to launch effective treatment alternatives are positively impacting the market growth.
Moreover, the presence of favorable medical reimbursement policies for the testing of sexually transmitted infections is contributing to the market growth. Other factors, such as the increasing prevalence of STDs, including syphilis, rising incidences of unprotected sexual intercourse, the widespread implementation of effective screening programs, and an enhanced focus on the early diagnostic of the disease, are creating a positive outlook for the market.
Syphilis refers to a sexually transmitted infection (STI) that is usually caused by sexual contact and is spread amongst individuals through the skin or mucous membrane contact. It starts as a painless sore on the genitals and rectum of the mouth. If left untreated, it might trigger complications of tertiary syphilis, wherein the disease may damage the brain, nerves, blood vessels, and joints.
At present, rapid plasma reagin (RPR) and venereal diseases research laboratory (VDRL) are standard testing practices that are being used by practitioners. These approaches provide early detection for better treatment and mitigate the spread and development of sexually transmitted diseases (STDs). As a result, syphilis testing is frequently used in laboratories and point-of-care (PoC) centers to diagnose the syphilis type and identify its proper treatment.
Syphilis Testing Market Trends
The increasing awareness regarding STD treatment represents one of the key factors driving the market growth. In line with this, governments of various nations, along with different non-governmental organizations (NGOs) are actively undertaking campaigns to sensitize the common mass regarding the prevention of STDs, including syphilis, and the available treatment options. This, in turn, is facilitating the adoption of syphilis testing kits, such as syphilis rapid test strips, which is favorably supporting the market growth. These kits offer at-home testing with effective diagnostic results, and thus timely decision-making, which is also contributing to the market growth.Additionally, the convenience of usage and the easy availability of these test kits at online retail stores and in-store pharmacies at affordable price points are contributing to the market growth. Apart from this, the considerable improvements in the healthcare sector and the recent research and development (R&D) activities to launch effective treatment alternatives are positively impacting the market growth.
Moreover, the presence of favorable medical reimbursement policies for the testing of sexually transmitted infections is contributing to the market growth. Other factors, such as the increasing prevalence of STDs, including syphilis, rising incidences of unprotected sexual intercourse, the widespread implementation of effective screening programs, and an enhanced focus on the early diagnostic of the disease, are creating a positive outlook for the market.
Key Market Segmentation
This report provides an analysis of the key trends in each segment of the global syphilis testing market, along with forecasts at the global, regional, and country level from 2024-2032. The report has categorized the market based on type and location of testing.Type Insights:
- Primary and Secondary Syphilis
- Latent and Tertiary Syphilis
Location of Testing Insights:
- Laboratory Testing
- Point-of-Care (POC) Testing
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape
The report has also provided a comprehensive analysis of the competitive landscape in the global syphilis testing market. Detailed profiles of all major companies have also been provided. Some of the companies covered includes Abbott Laboratories, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, DRG International Inc. (BioCheck Inc.), F. Hoffmann-La Roche AG, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.Key Questions Answered in This Report
- How has the global syphilis testing market performed so far and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global syphilis testing market?
- What are the key regional markets?
- Which countries represent the most attractive syphilis testing markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the location of testing?
- What is the competitive structure of the global syphilis testing market?
- Who are the key players/companies in the global syphilis testing market?
Table of Contents
1 Preface3 Executive Summary10 Value Chain Analysis12 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Syphilis Testing Market
6 Market Breakup by Type
7 Market Breakup by Location of Testing
8 Market Breakup by Region
9 Drivers, Restraints, and Opportunities
11 Porters Five Forces Analysis
13 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Becton Dickinson and Company
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- DRG International Inc. (BioCheck Inc.)
- F. Hoffmann-La Roche AG
- Siemens Healthineers AG (Siemens AG)
- Thermo Fisher Scientific Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 137 |
| Published | April 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 1.2 Billion |
| Forecasted Market Value ( USD | $ 1.9 Billion |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
